Assessing the molecular interaction between a COVID-19 drug, nirmatrelvir, and human serum albumin: calorimetric, spectroscopic, and microscopic investigations
-
Mujaheed Abubakar
Abstract
The research examined the molecular interaction between nirmatrelvir (NIR), a drug used to treat COVID-19, and human serum albumin (HSA) using various techniques, viz., isothermal titration calorimetry (ITC), absorption, fluorescence, CD spectroscopy, and atomic force microscopy (AFM). ITC analysis showed that the NIR–HSA system possessed a moderate binding affinity, with a K a value of 6.53 ± 0.23 × 104 M−1 at a temperature of 300 K. The thermodynamic values demonstrated that the NIR–HSA complex was stabilized by hydrophobic contacts, hydrogen bonds, and van der Waals forces. The research also discovered modifications in the UV–Vis absorption spectrum of the protein as well as swelling of the HSA molecule when exposed to NIR, based on AFM results. The three-dimensional fluorescence spectral data indicated changes in the microenvironment around HSA’s Trp and Tyr residues. Alterations in the protein structure (both secondary and tertiary structures) of HSA after NIR binding were verified using CD spectral studies in the far-UV and near-UV regions. The identification of the NIR binding site in subdomain IB (Site III) of HSA was predicted through competitive displacement experiments.
Funding source: UCSI University
Award Identifier / Grant number: REIG grant (REIG-FPS-2023/039)
Acknowledgments
The authors express their gratitude to the Institute of Biological Sciences, Faculty of Science and Faculty of Dentistry, Universiti Malaya for the essential support and resources that significantly contributed to their research. Additionally, they acknowledge the financial support from the UCSI University REIG grant (REIG-FPS-2023/039) sanctioned to Saad Tayyab.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: Investigation, formal analysis, original draft: Mujaheed Abubakar; investigation, formal analysis: Ahmad Fadhlurrahman Ahmad Hidayat; supervision: Adyani Azizah Abd Halim; supervision: Kushagra Khanna; review and editing: Mohammed Suleiman Zaroog; fund acquisition, supervision: Mogana Sundari Rajagopal; conceptualization, fund acquisition, visualization, supervision, final draft: Saad Tayyab.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: The authors state no conflict of interest.
-
Research funding: UCSI University REIG grant (REIG-FPS-2023/039).
-
Data availability: Data will be made available on reasonable request from the corresponding author.
References
1. Jamison, DAJr, Narayanan, SA, Trovão, NS, Guarnieri, JW, Topper, MJ, Moraes-Vieira, PM, et al.. A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: intracellular overdrive for SARS-CoV-2 infection. Eur J Hum Genet 2022;30:889–98. https://doi.org/10.1038/s41431-022-01108-8.Search in Google Scholar PubMed PubMed Central
2. Pawełczyk, A, Zaprutko, L. Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives. Future Med Chem 2020;12:1743–57. https://doi.org/10.4155/fmc-2020-0204.Search in Google Scholar PubMed PubMed Central
3. Trusova, VM, Zhytniakivska, OA, Tarabara, UK, Vus, KA, Gorbenko, GP. Deciphering the molecular details of interactions between anti-COVID drugs and functional human proteins: in silico approach. J Pharm Biomed Anal 2023;233:115448. https://doi.org/10.1016/j.jpba.2023.115448.Search in Google Scholar PubMed
4. Laurie, KL, Rockman, S. Which influenza viruses will emerge following the SARS‐CoV‐2 pandemic? Influ Other Respir Virus 2021;15:573–6. https://doi.org/10.1111/irv.12866.Search in Google Scholar PubMed PubMed Central
5. Ghahremanian, S, Rashidi, MM, Raeisi, K, Toghraie, D. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review. J Mol Liq 2022;354:118901. https://doi.org/10.1016/j.molliq.2022.118901.Search in Google Scholar PubMed PubMed Central
6. Raj, ST, Bruce, AW, Anbalagan, M, Srinivasan, H, Chinnappan, S, Rajagopal, M, et al.. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens. Front Cell Infect Microbiol 2024;14:1384939. https://doi.org/10.3389/fcimb.2024.1384939.Search in Google Scholar PubMed PubMed Central
7. Vuignier, K, Schappler, J, Veuthey, J-L, Carrupt, P-A, Martel, S. Drug-protein binding: a critical review of analytical tools. Anal Bioanal Chem 2010;398:53–66. https://doi.org/10.1007/s00216-010-3737-1.Search in Google Scholar PubMed
8. Colmenarejo, G. In silico prediction of drug-binding strengths to human serum albumin. Med Res Rev 2003;23:275–301. https://doi.org/10.1002/med.10039.Search in Google Scholar PubMed
9. Fasano, M, Curry, S, Terreno, E, Galliano, M, Fanali, G, Narciso, P, et al.. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 2005;57:787–96. https://doi.org/10.1080/15216540500404093.Search in Google Scholar PubMed
10. Ebrahimi, M, Khayamian, T, Hadadzadeh, H, Tabatabaei, BES, Jannesari, Z, Khaksar, G. Spectroscopic, biological, and molecular modeling studies on the interactions of [Fe (III)-meloxicam] with G-quadruplex DNA and investigation of its release from bovine serum albumin (BSA) nanoparticles. J Biomol Struct Dyn 2015;33:2316–29. https://doi.org/10.1080/07391102.2014.1003195.Search in Google Scholar PubMed
11. Kabir, MZ, Feroz, SR, Mukarram, AK, Alias, Z, Mohamad, SB, Tayyab, S. Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking. J Biomol Struct Dyn 2016;34:1693–704. https://doi.org/10.1080/07391102.2015.1089187.Search in Google Scholar PubMed
12. Kragh-Hansen, U, Chuang, VTG, Otagiri, M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 2002;25:695–704. https://doi.org/10.1248/bpb.25.695.Search in Google Scholar PubMed
13. Petitpas, I, Bhattacharya, AA, Twine, S, East, M, Curry, S. Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J Biol Chem 2001;276:22804–9. https://doi.org/10.1074/jbc.m100575200.Search in Google Scholar
14. Wani, TA, Bakheit, AH, Zargar, S, Hamidaddin, MA, Darwish, IA. Spectrophotometric and molecular modelling studies on in vitro interaction of tyrosine kinase inhibitor linifanib with bovine serum albumin. PLoS One 2017;12:e0176015. https://doi.org/10.1371/journal.pone.0176015.Search in Google Scholar PubMed PubMed Central
15. Sattar, Z, Saberi, MR, Chamani, J. Determination of LMF binding site on a HSA-PPIX complex in the presence of human holo transferrin from the viewpoint of drug loading on proteins. PLoS One 2014;9:e84045. https://doi.org/10.1371/journal.pone.0084045.Search in Google Scholar PubMed PubMed Central
16. Sharif-Barfeh, Z, Beigoli, S, Marouzi, S, Rad, AS, Asoodeh, A, Chamani, J. Multi-spectroscopic and HPLC studies of the interaction between estradiol and cyclophosphamide with human serum albumin: binary and ternary systems. J Solut Chem 2017;46:488–504. https://doi.org/10.1007/s10953-017-0590-2.Search in Google Scholar
17. Fitos, I, Simon, Á, Zsila, F, Mády, G, Bencsura, Á, Varga, Z, et al.. Characterization of binding mode of imatinib to human α1-acid glycoprotein. Int J Biol Macromol 2012;50:788–95. https://doi.org/10.1016/j.ijbiomac.2011.11.023.Search in Google Scholar PubMed
18. Millan, S, Satish, L, Kesh, S, Chaudhary, YS, Sahoo, H. Interaction of lysozyme with rhodamine B: a combined analysis of spectroscopic & molecular docking. J Photochem Photobiol, B 2016;162:248–57. https://doi.org/10.1016/j.jphotobiol.2016.06.047.Search in Google Scholar PubMed
19. Soares, S, Mateus, N, De Freitas, V. Interaction of different polyphenols with bovine serum albumin (BSA) and human salivary α-amylase (HSA) by fluorescence quenching. J Agric Food Chem 2007;55:6726–35. https://doi.org/10.1021/jf070905x.Search in Google Scholar PubMed
20. Sudlow, G, Birkett, D, Wade, D. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 1976;12:1052–61.Search in Google Scholar
21. Zsila, F. Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model. Mol Pharm 2013;10:1668–82. https://doi.org/10.1021/mp400027q.Search in Google Scholar PubMed
22. Painter, L, Harding, MM, Beeby, PJ. Synthesis and interaction with human serum albumin of the first 3,18-disubstituted derivative of bilirubin. J Chem Soc Perkin 1998;1:3041–4. https://doi.org/10.1039/a803429j.Search in Google Scholar
23. Papadopoulou, A, Green, RJ, Frazier, RA. Interaction of flavonoids with bovine serum albumin: a fluorescence quenching study. J Agric Food Chem 2005;53:158–63. https://doi.org/10.1021/jf048693g.Search in Google Scholar PubMed
24. Sapi, E, Pabbati, N, Datar, A, Davies, EM, Rattelle, A, Kuo, BA. Improved culture conditions for the growth and detection of borrelia from human serum. Int J Med Sci 2013;10:362–76. https://doi.org/10.7150/ijms.5698.Search in Google Scholar PubMed PubMed Central
25. Abubakar, M, Mohamad, SB, Halim, AAA, Tayyab, S. Unveiling the molecular interaction of hepatitis B virus inhibitor, entecavir with human serum albumin through computational, microscopic and spectroscopic approaches. J Biomol Struct Dyn 2024:1–14. https://doi.org/10.1080/07391102.2024.2311331.Search in Google Scholar PubMed
26. Abubakar, M, Kandandapani, S, Mohamed, SB, Halim, AAA, Tayyab, S. Shedding light on the molecular interaction between the hepatitis B virus inhibitor, clevudine, and human serum albumin: thermodynamic, spectroscopic, microscopic, and in silico analyses. J Mol Liq 2022;368:120737. https://doi.org/10.1016/j.molliq.2022.120737.Search in Google Scholar
27. Yang, H, Huang, Y, Liu, J, Tang, P, Sun, Q, Xiong, X, et al.. Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies. Sci Rep 2017;7:11126. https://doi.org/10.1038/s41598-017-11604-3.Search in Google Scholar PubMed PubMed Central
28. Kandandapani, S, Kabir, MZ, Ridzwan, NFW, Mohamad, SB, Tayyab, S. Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach. J Biomol Struct Dyn 2022;40:8312–23. https://doi.org/10.1080/07391102.2021.1911850.Search in Google Scholar PubMed
29. Shahabadi, N, Falsafi, M, Hadidi, S. Molecular modeling and multispectroscopic studies of the interaction of hepatitis B drug, adefovir dipivoxil with human serum albumin. J Lumin 2015;167:339–46. https://doi.org/10.1016/j.jlumin.2015.07.006.Search in Google Scholar
30. Shahabadi, N, Zendehcheshm, S, Momeni, BZ, Abbasi, R. Antiproliferative activity and human serum albumin binding propensity of [SnMe2Cl2 (bu2bpy)]: multi-spectroscopic analysis, atomic force microscopy, and computational studies. J Coord Chem 2020;73:1349–76. https://doi.org/10.1080/00958972.2020.1775821.Search in Google Scholar
31. Tayyab, S, Magesvaran, MKA, Kabir, MZ, Ridzwan, NFW, Mohamad, SB. Biophysical and computational view on the in vitro combination between an anticancer drug, saracatinib and human serum albumin. J Biomol Struct Dyn 2021;39:3565–75. https://doi.org/10.1080/07391102.2020.1766571.Search in Google Scholar PubMed
32. Zhang, H-X, Zhou, D, Xia, Q-H. Study on the molecular recognition action of lamivudine by human serum albumin. J Mol Recogn 2018;31:e2705. https://doi.org/10.1002/jmr.2705.Search in Google Scholar PubMed
33. Du, X, Li, Y, Xia, Y-L, Ai, S-M, Liang, J, Sang, P, et al.. Insights into protein–ligand interactions: mechanisms, models, and methods. Int J Mol Sci 2016;17:144. https://doi.org/10.3390/ijms17020144.Search in Google Scholar PubMed PubMed Central
34. Sharifi-Rad, A, Mehrzad, J, Darroudi, M, Saberi, MR, Chamani, J. Oil-in-water nanoemulsions comprising Berberine in olive oil:biological activities, binding mechanisms to human serum albumin or holo-transferrin and QMMDsimulations. J Biomol Struct Dyn 2020;39:1029–43. https://doi.org/10.1080/07391102.2020.1724568.Search in Google Scholar PubMed
35. Ross, PD, Subramanian, S. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry 1981;20:3096–102. https://doi.org/10.1021/bi00514a017.Search in Google Scholar PubMed
36. Khalili, L, Dehghan, G. A comparative spectroscopic, surface plasmon resonance, atomic force microscopy and molecular docking studies on the interaction of plant derived conferone with serum albumins. J Lumin 2019;211:193–202. https://doi.org/10.1016/j.jlumin.2019.03.048.Search in Google Scholar
37. Kolawole, AO, Kolawole, AN, Olofinsan, KA, Elekofehinti, OO. Kolaflavanone of kolaviron selectively binds to subdomain 1B of human serum albumin: spectroscopic and molecular docking evidences. Comput Toxicol 2020;13:100118. https://doi.org/10.1016/j.comtox.2020.100118.Search in Google Scholar
38. Rahman, S, Rehman, MT, Rabbani, G, Khan, P, AlAjmi, MF, Hassan, MI, et al.. Insight of the interaction between 2, 4-thiazolidinedione and human serum albumin: a spectroscopic, thermodynamic and molecular docking study. Int J Mol Sci 2019;20:2727. https://doi.org/10.3390/ijms20112727.Search in Google Scholar PubMed PubMed Central
39. Kabir, MZ, Tayyab, H, Erkmen, C, Kurbanoglu, S, Mohamad, SB, Uslu, B. Characterization of climbazole–bovine serum albumin interaction by experimental and in silico approaches. Spectrochim Acta 2023;288:122197.10.1016/j.saa.2022.122197Search in Google Scholar PubMed
40. Dong, S, Li, Z, Shi, L, Huang, G, Chen, S, Huang, T. The interaction of plant-growth regulators with serum albumin: molecular modeling and spectroscopic methods. Food Chem Toxicol 2014;67:123–30. https://doi.org/10.1016/j.fct.2014.02.020.Search in Google Scholar PubMed
41. Makarska-Bialokoz, M, Lipke, A. Study of the binding interactions between uric acid and bovine serum albumin using multiple spectroscopic techniques. J Mol Liq 2019;276:595–604. https://doi.org/10.1016/j.molliq.2018.12.026.Search in Google Scholar
42. Wang, X, Liu, Y, He, L-L, Liu, B, Zhang, S-Y, Ye, X, et al.. Spectroscopic investigation on the food components–drug interaction: the influence of flavonoids on the affinity of nifedipine to human serum albumin. Food Chem Toxicol 2015;78:42–51. https://doi.org/10.1016/j.fct.2015.01.026.Search in Google Scholar PubMed
43. Sun, Q, Gan, N, Zhang, S, Zhao, L, Tang, P, Pu, H, et al.. Insights into protein recognition for γ-lactone essences and the effect of side chains on interaction via microscopic, spectroscopic, and simulative technologies. Food Chem 2019;278:127–35. https://doi.org/10.1016/j.foodchem.2018.11.037.Search in Google Scholar PubMed
44. Lakowicz, JR. Principles of fluorescence spectroscopy. New York, NY: Springer; 2006.10.1007/978-0-387-46312-4Search in Google Scholar
45. Molina-Bolívar, J, Galisteo-González, F, Ruiz, CC, Medina-O’Donnell, M, Parra, A. Spectroscopic investigation on the interaction of maslinic acid with bovine serum albumin. J Lumin 2014;156:141–9.10.1016/j.jlumin.2014.08.011Search in Google Scholar
46. Tayyab, S, Zaroog, MS, Feroz, SR, Mohamad, SB, Malek, SNA. Exploring the interaction between the antiallergic drug, tranilast and human serum albumin: insights from calorimetric, spectroscopic and modeling studies. Int J Pharm 2015;491:352–8. https://doi.org/10.1016/j.ijpharm.2015.06.042.Search in Google Scholar PubMed
47. Zhu, X, Hu, Y, Gong, A. Investigation on the interaction of tetrachloride fluorescein–bovine serum albumin-β-cyclodextrin and the determination of protein by flow injection analysis. Anal Chim Acta 2007;592:24–9. https://doi.org/10.1016/j.aca.2007.03.053.Search in Google Scholar PubMed
48. Ansari, SS, Khan, RH, Naqvi, S. Probing the intermolecular interactions into serum albumin and anthraquinone systems: a spectroscopic and docking approach. J Biomol Struct Dyn 2018;36:3362–75. https://doi.org/10.1080/07391102.2017.1388284.Search in Google Scholar PubMed
49. Kelly, SM, Jess, TJ, Price, NC. How to study proteins by circular dichroism. BBA-Proteins Proteom 2005;1751:119–39. https://doi.org/10.1016/j.bbapap.2005.06.005.Search in Google Scholar PubMed
50. Sudlow, G, Birkett, D, Wade, D. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 1975;11:824–32.10.1016/S0026-895X(25)10691-3Search in Google Scholar
51. Abubakar, M, Mohamad, SB, Zaroog, MS, Mahboob, T, Rajagopal, MS, Tayyab, S. Nirmatrelvir, a COVID-19 drug, and human serum albumin: computational analysis of their molecular interactions. ChemistrySelect 2024;9:e202400604. https://doi.org/10.1002/slct.202400604.Search in Google Scholar
© 2025 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review Articles
- Phyto-pharmaceuticals as a safe and potential alternative in management of psoriasis: a review
- Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook
- Antidiabetic phytochemicals: an overview of medicinal plants and their bioactive compounds in diabetes mellitus treatment
- Pharmacological and toxicological profile of the Stachys lavandulifolia Vahl: a comprehensive review
- Research Articles
- Essential oil composition, in vitro antidiabetic, cytotoxicity, antimicrobial, antioxidant activity, and in silico molecular modeling analysis of secondary metabolites from Justicia schimperiana
- French marigold (Tagetes patula) flavonoid extract-based priming ameliorates initial drought stress on Oryza sativa var indica, cultivar Satabdi (IET4786): a sustainable approach to avoid initial drought stress
- Assessing the molecular interaction between a COVID-19 drug, nirmatrelvir, and human serum albumin: calorimetric, spectroscopic, and microscopic investigations
- Insight into in vitro thymidine phosphorylase and in silico molecular docking studies: identification of hybrid thiazole bearing Schiff base derivatives
- In vivo evaluation of the antinociceptive effects of novel methylsulfonyl group-containing compounds
Articles in the same Issue
- Frontmatter
- Review Articles
- Phyto-pharmaceuticals as a safe and potential alternative in management of psoriasis: a review
- Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook
- Antidiabetic phytochemicals: an overview of medicinal plants and their bioactive compounds in diabetes mellitus treatment
- Pharmacological and toxicological profile of the Stachys lavandulifolia Vahl: a comprehensive review
- Research Articles
- Essential oil composition, in vitro antidiabetic, cytotoxicity, antimicrobial, antioxidant activity, and in silico molecular modeling analysis of secondary metabolites from Justicia schimperiana
- French marigold (Tagetes patula) flavonoid extract-based priming ameliorates initial drought stress on Oryza sativa var indica, cultivar Satabdi (IET4786): a sustainable approach to avoid initial drought stress
- Assessing the molecular interaction between a COVID-19 drug, nirmatrelvir, and human serum albumin: calorimetric, spectroscopic, and microscopic investigations
- Insight into in vitro thymidine phosphorylase and in silico molecular docking studies: identification of hybrid thiazole bearing Schiff base derivatives
- In vivo evaluation of the antinociceptive effects of novel methylsulfonyl group-containing compounds